CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026

CV Sciences, Inc. (OTCQB: CVSI) said it will report second-quarter 2026 results for the quarter ended June 30, 2026 after the market closes on Aug. 13, 2026. The company will host a conference call and webcast at 1:30 p.m. PT the same day, with a replay available through Aug. 20.

Original reporting
Published Aug 11, 2026, 1:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 1:52 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CVSI
Neutral
medium confidence
Mentioned
$CVSI
Relevance
5/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$CVSINeutralMed
01

Why it matters

The primary tradable element is the earnings event timing, which can drive pre-earnings positioning and after-hours repricing once results are published.

02

Market read

This sets a clear catalyst date for CVSI, but the article contains no earnings numbers, guidance, or other fundamental surprises.

03

What to watch

For OTC names, liquidity and positioning can dominate price action; the call timing and after-hours release can amplify moves even without new guidance in the announcement.

Relevance 5/10Novelty 5/10Timing: Ahead of the Aug. 13, 2026 after-hours Q2 2026 results release and 1:30 p.m. PT call.

Background

CV Sciences (OTCQB: CVSI) is a consumer wellness company focused on hemp extracts and related natural ingredients, and it scheduled its Q2 2026 earnings release and investor call.

Company-level read

Ticker impact

$CVSINeutralMedium confidence
Context

CV Sciences announced it will release Q2 2026 results after the close on Aug. 13, 2026, with a conference call that evening.

Expected impact

Likely elevated volatility into the Aug. 13 after-hours print, with direction dependent on the Q2 results and guidance to be disclosed.

Evidence & confidence

The article discloses timing (after-hours Aug. 13) and call logistics, but provides no financial figures or guidance, so the directional impact is unknown.

Market effects

Limited sector read-through because the release is company-specific and contains no new industry/regulatory developments.

Minimal, as the event is OTC-listed and not a broad macro driver.

Low, no international policy, supply chain, or cross-border deal details are provided.

Counterpoint

Traders may treat this as low-signal because it only confirms the calendar, not expectations or changes in fundamentals.

Key entities

  • CV Sciences, Inc.

    OTCQB-listed consumer wellness company scheduling Q2 2026 results for Aug. 13, 2026 after the close.

  • Conference call

    Scheduled for Aug. 13, 2026 at 1:30 p.m. Pacific (4:30 p.m. Eastern).

Related articles

$KITTMedAI 8/10

Nauticus Robotics, Inc. Reports Second Quarter 2026 Results and Advances Commercialization Strategy

Nauticus Robotics (NASDAQ: KITT) reported Q2 2026 revenue of $0.9 million, down from $2.1 million in Q2 2025 and $0.2 million in Q1 2026. Adjusted net loss was $7.0 million, compared with $7.46 million in Q2 2025 and $6.4 million in Q1 2026. Cash was $2.0 million at June 30, 2026. The company highlighted ToolKITT commercialization, market expansion, and defense work.

$VOXRMedAI 8/10

Vox Royalty Corp.: Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend

Vox Royalty Corp. (NASDAQ:VOXR) reported Q2 2026 results for the quarter ended June 30, 2026, including net income of $17.0 million, or $0.25/share, and adjusted EBITDA of $9.7 million, or $0.14/share. Cash was $31.1 million. The company reiterated 2026 guidance of $32 million to $37 million and declared a $0.015 quarterly dividend payable Oct. 14, 2026.

$ENSHighAI 9/10

Expected Sales In Q2 CY2026, Stock Jumps 14.1%

EnerSys (NYSE: ENS) reported Q2 CY2026 revenue of $935.6 million, up 4.8% year on year, beating market expectations by 0.8%. Non-GAAP EPS was $3.66, 29.5% above consensus. The company guided next-quarter revenue near $975 million and EPS guidance above estimates. Shares rose 14.1% to $213.00 after results.

$EATMedAI 8/10

Brinker International (EAT) Shares Skyrocket, What You Need To Know

Brinker International (NYSE: EAT) shares rose about 12% after mixed fiscal Q4 results and strong 2027 guidance. Adjusted EPS was $3.07, slightly below estimates, while revenue was $1.54B above forecasts on higher same-store sales. The company guided 2027 adjusted EPS to $13.00 (midpoint) and revenue above consensus; shares closed at $245.71.